Drugdiscovery >> Drug Development >> News
2701
Views
Novartis looks forward to have its new drug accepted in the EU - drugdiscovery.com
Novartis looks forward to have its new drug accepted in the EU - drugdiscovery.com


Novartis has announced that it has submitted the revised service pack of Serelaxin to Committee for Medicinal Products for Human Use (CHMP). This drug is used in case of chronic heart failure.
Read More >>


Tags: chronic heart failure, Committee for Medicinal Products for Human Use, Serelaxin - January 29, 2014
Related Articles
1226
Views
New drug of Novartis and Lilly was successful in trials New drug of Novartis and Lilly was successful in trials
Phase III REVEL study data say that the new drug of Novartis and Lilly is effective in metastatic non-small cell lung cancer cases. Ramucirumab showed very good results in clinical tests. Read More >>

Tags: Ramucirumab, chemotherapy, cancer, Lilly, Novartis

3501
Views
Multiple Myeloma drug of Novartis is promising Multiple Myeloma drug of Novartis is promising
Multiple myeloma drug on Novartis prooved to be effective in Phase III trials. Panobinostat in combination with bortezomib and dexamethasone seems to be more effecite than bortezomib plus dexamethaso Read More >>

Tags: bortezomib, dexamethasone, myeloma, Novartis

4342
Views
Fabricated Data in Novartis Drug Trial Fabricated Data in Novartis Drug Trial
Japanese minister confirms that data from a large Japanese study was fabricated. Read More >>

Tags: Novartis, Diovan, drug trial

1385
Views
Heart drug of novertis was rejected by FDA Heart drug of novertis was rejected by FDA
Cardiovascular and Renal Drugs Advisory Committee has rejected a new heart drug of Novartis. Serelaxin was not apporved due to lack of data. Read More >>

Tags: Serelaxin, heart failure, cardiovascular disease, novartis, FDA, FDA rejection

1610
Views
A step-forward in the field of paediatric drugs A step-forward in the field of paediatric drugs
Astra zeneca has made a step-forward in the field of paediatric drug-research. The cosnurtium of Molecular Profiles along with Pfizer, Bristol Myers Squibb, GlaxoSmithKline and academic institutions i Read More >>

Tags: Astra Zeneca, paediatric drugs, pharma

7053
Views
Novartis' Serelaxin is a breakthrough in heart drug development Novartis' Serelaxin is a breakthrough in heart drug development
Novartis have given breakthrough therapy status by FDA to an investigational treatment for patients with acute heart failure. Read More >>

Tags: heart failure,drug,Serelaxin

4782
Views
New Psoriasis Drug Better Than Enbrel New Psoriasis Drug Better Than Enbrel
Secukinumab, a new drug from Novartis, was found to be better than Enbrel at curing psoriasis. Read More >>

Tags: Secukinumab, Novartis, Enbrel, psoriasis, Amgen

4338
Views
Menveo Approved for Toddlers Menveo Approved for Toddlers
Menveo, a quadrivalent conjugate vaccine used to protect against invasive meningococcal disease caused by four groups of the bacterium Neisseria meningitidis approved for use in infants as young as 2 Read More >>

Tags: Menveo, Novartis, Meningococcal disease

8812
Views
FDA asks for input on antibiotic drug discovery FDA asks for input on antibiotic drug discovery
A US Food and Drug Administration (FDA) taskforce working on advancing antibiotic drug development has outlined its initial areas of interest, and proposed a list of pathogens that could trigger exte Read More >>

Tags: antibiotic drug development, FDA, drug candidate

5677
Views
Electric controll of drug can prevent side-effects Electric controll of drug can prevent side-effects
Several drugs have side effects because they are active in those parts of the body where they should not be. A group of scientists created a "smart" implant, which might solve this problem. Read More >>

Tags: smart implant, scientists, side effects, drug development, electronic drug control

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013